Jianfeng Group Lin2017 -021 (Announcement of Resolutions of the 15th Session of the 9th Board of Directors)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-021
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Ninth Session 15 Board Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2017# On August 14, 31, the company issued the notice of the board meeting by fax, e-mail and personal service.
(III) 2017# On August 25, 34, the board meeting was held in the conference room on the third floor of Jianfeng Building in Jinhua City, Zhejiang Province by a combination of on-site and communication voting.(IV) 9
directors who should attend this board meeting, 9 directors who actually attended the meeting, 9 valid votes at the meeting, directors Huang Sujian and Zhu Linming, independent directors Sun Hongbin and Huang Congyun voted by communication.(V) The board of directors was presided over by Chairman Jiang Xiaomeng, and the company's supervisors and senior management attended the meeting.
2. Board Meeting Review
1
, Passed 2017Semi-annual Report and Its Summary After deliberation and voting, the Board of Directors passed the Company's 2017
Semi-annual Report and its summary.Voting Result: 9
votes in favor, 0 votes against, 0 abstentions. For details of, please refer to the Company's "2017 Semi-Annual Report" and its summary disclosed on August 29, 2017
.2
, passed the proposal on the change of the company's accounting policyaccording to the "notice on printing and distributing <accounting standards for enterprises no 42
-non-current assets held for sale, disposal group and termination of operations> issued by the Ministry of finance" (accounting [2017] no 13), "on issuing and revising <accounting standards for enterprises no 16-government subsidies> (Cai [2017] No. 15), the Company has made changes to the relevant accounting policies. For details, please refer to the Company's Announcement No. 2017-025 "Announcement on Changes in the Company's Accounting Policy".Independent directors expressed their independent opinions on this, believing that the change in the company's accounting policy is a reasonable change made by the company in accordance with the requirements of relevant documents of the Ministry of Finance, in line with the Accounting Standards for Business Enterprises and relevant regulations, and its decision-making procedures are in line with relevant laws, regulations and the company's articles of association, and do not harm the interests of the company and minority shareholders.
After deliberation and voting, the board of directors passed the bill.
Voting result: 9
votes in favor, 0 votes against and 0 abstentions., passed the proposal
meeting on authorizing the chairman to use idle self-owned funds for entrusted financial management. on the premise of ensuring the company's daily operation and fund safety, the chairman is authorized to exercise the decision-making power of entrusted financial management not exceeding RMB 2
.7 billion yuan, within which funds can be used on a rolling basis, however, the total balance of entrusted financial management surviving at any point in time shall not exceed 0.2 billion yuan. The term of each entrusted financial management shall not exceed 12 months. The authorization period shall be valid for 3 years from the date of approval by the board of directors of the company.The independent directors of the company issued an independent opinion on the resolution, and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.
For details, please refer to the Announcement on Authorizing the Chairman to Decide on Entrusting Financial Management (P.2017 -024
).After deliberation and voting, the board of directors passed the bill. Voting result of
: 9
votes in favor, 0 votes against and 0 abstentions.4
, passed the entrusted financial management systemAfter deliberation and voting, the board of directors passed the entrusted financial management system. For details, please refer to the "Entrusted Financial Management System" disclosed by the Company on the website of the Shanghai Stock Exchange.
Voting Result: 9
votes in favor, 0 votes against, 0 abstentions.3. Internet Announcement Annex
1
, the opinions of the 9th independent director of the company on the above related matters.2
, Entrusted Financial Management System
This is to announce
Zhejiang Jianfeng Group Co., Ltd.
Board of DirectorsAugust 29, 2017
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31